Medication info
Memantine White Tablet (Memantine Hydrochloride)

Memantine White Tablet (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
White Life Science Co., Ltd.
Appearance
White elongated film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202003931 · Approved 2020.05.27 · Insurance code 625202290

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medication is administered orally once daily at the same time each day. If necessary, it may be administered twice daily. This medication may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Day 1–7) Administer 5mg once daily for 7 days. Week 2 (Day 8–14) Administer 10mg once daily for 7 days. Week 3 (Day 15–21) Administer 15mg once daily for 7 days. From Week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults: Based on clinical data, the recommended dose for older patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-escalation method. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medication.

Ingredients

Manufacturer
White Life Science Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used to alleviate symptoms in patients with moderate to severe Alzheimer's disease and to slow the progression of the disease.

How to take

Adult dose

This medication is administered orally once daily at the same time each day. If necessary, it may be administered twice daily. This medication may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Day 1–7) Administer 5mg once daily for 7 days. Week 2 (Day 8–14) Administer 10mg once daily for 7 days. Week 3 (Day 15–21) Administer 15mg once daily for 7 days. From Week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults: Based on clinical data, the recommended dose for older patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-escalation method. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medication.

Precautions

This medication should not be used in patients with allergic reactions to any of its components. Additionally, it is safe to avoid administering it to patients with very poor liver function or severely impaired kidney function. Caution should be taken when using it in patients with epilepsy or those with a history of seizures, and in patients at risk of developing seizures. When taken with other NMDA antagonists, side effects may worsen, so co-administration is not recommended. Patients with factors affecting urinary acidity (pH) should be carefully monitored. There is insufficient safety data for patients with heart disease or uncontrolled hypertension, so caution is necessary. While taking this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, so symptoms should be closely monitored. Rarely, neurological symptoms such as mental confusion, hallucinations, and seizures may occur, so if any unusual symptoms arise, consultation with a physician is advised. This medication may interact with other drugs, so patients should inform their physician about any medications they are taking, especially when used with certain antipsychotics or antihypertensives. Women who are pregnant or may become pregnant should carefully consider the use of this medication as it may affect the fetus, and a discussion with a physician is recommended. If breastfeeding, it is recommended to discontinue breastfeeding as this medication may be transmitted in breast milk. Safety and efficacy in children and adolescents under 18 years of age have not been established. If an overdose occurs, central nervous system symptoms or gastrointestinal symptoms may appear, and prompt medical attention should be sought, as there is no specific antidote, and treatment will be symptomatic. Patients taking this medication should be cautious when driving or operating machinery, especially Alzheimer's patients who may experience a slowed reaction time, so safety should be prioritized. Finally, this medication should be kept out of the reach of children, and it is advisable not to transfer it to another container.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity
  • confusion
  • hallucinations
  • psychotic reactions
Show 22 more
  • balance disorder
  • gait abnormalities
  • seizures
  • heart failure
  • venous thrombosis/thromboembolism
  • shortness of breath
  • vomiting
  • pancreatitis
  • elevated liver function test values
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • restlessness
  • aggression
  • delirium
  • unconsciousness
  • double vision
  • agitation
  • psychosis
  • visual hallucinations

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. This will help ensure the effectiveness of the medication over time.

Appearance and packaging

Appearance

White elongated film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.